Literature DB >> 18635104

Protease activity associated with the capsule protein of Estigmene acres granulosis virus.

W H Langridge1, K Balter.   

Abstract

The polypeptide composition of a granulosis virus of Estigmene acrea was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Enveloped nucleocapsids are made up of 24 polypeptides with molecular weights ranging from 11,000 to 98,000. Virus capsule protein contains protease activity which degrades capsule protein from 30,000 to 25,000 through two intermediates of 29,000 and 27,000. The putative endoprotease is active at alkaline pH, sensitive to heat and diethylpyrocarbonate inhibition, and resistant to 10(-3) M phenylmethylsulfonyl fluoride. No alteration in the electrophoretic pattern of viral structural proteins was detected in virus preparations containing endoproteolytic activity. A low level of alkaline exoprotease activity associated with capsule protein was also detected.

Entities:  

Year:  1981        PMID: 18635104     DOI: 10.1016/0042-6822(81)90243-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Origin of an alkaline protease associated with the capsule of a granulosis virus of the armyworm, Pseudaletia unipuncta (Haworth).

Authors:  M Nagata; Y Tanada
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

2.  In situ cleavage of baculovirus occlusion-derived virus receptor binding protein P74 in the peroral infectivity complex.

Authors:  Ke Peng; Jan W M van Lent; Just M Vlak; Zhihong Hu; Monique M van Oers
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

3.  Further characterization of an alkaline protease activity associated with iridescent virus type 6. Brief report.

Authors:  T Farara; J Attias
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 4.  The baculoviruses occlusion-derived virus: virion structure and function.

Authors:  Jeffery Slack; Basil M Arif
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.